Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Gracell Biotechnologies (shanghai) Co., Ltd.

Clinical trials sponsored by Gracell Biotechnologies (shanghai) Co., Ltd., explained in plain language.

Now part of AstraZeneca PLC AZN NASDAQ

Clinical-stage biopharmaceutical company developing cell therapies for cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1

New injection aims to tame lupus when standard treatments fail

Disease control Ongoing

This early-stage study tests an injection called GC012F in 20 adults with refractory systemic lupus erythematosus (SLE) — a type of lupus that hasn't responded to standard treatments. The goal is to see if the therapy is safe and can reduce disease activity. Participants receive …

Phase: PHASE1, PHASE2 • Sponsor: Gracell Biotechnologies (Shanghai) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:05 UTC